Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
One of the biggest challenges that doctors and scientists are faced with today is developing a cure for the deadly virus known as HIV or AIDS. Having become prevalent for decades, responsible for taking millions of lives, everyone is on the search for a cure, and patients are willing to risk their lives to make it happen.
As the HIV/AIDS epidemic rages on, there has been some progress made towards developing a cure to the deadly disease over recent years. A new study on the disease, titled “HIV Cure Research,” revealed that a portion of people who are HIV-positive are willing to risk their lives in the clinical trials. To them, they are willing to risk near-certain death if it means helping in developing a cure. According to a patient that was interviewed, “I’m not going to live forever… It is about the next man, the next woman, and you have to have the mindset to care about people, which I do.”
Another patient that was also interviewed explained that they are willing to go this far for the community living with the disease. They expressed their hope at how much of a game-changer it would be to see a cure made.
On the other hand, the authors of the study explained that if HIV-positive patients are allowed to volunteer for the experiments, they said that there should be ethical safeguards placed. This is to ensure that patients have a say in their involvement in research that has the possibility to be fatal for them.
Everyone is putting a united front in battling the disease to put a stop to the epidemic once and for all. Scientists from the University of Nebraska Medical Center and Temple University were able to come up with a kind of therapy that cured the virus of living animals. This was the biggest breakthrough towards the journey for the cure to HIV/AIDS, and the future is bright for the cure for humans.
According to Dr. Howard Gendelman of the University of Nebraska, they are moving closer to making human trials for the type of therapy that could potentially cure HIV/AIDS. Referred to as LASER-ART - which is a slow-effect release antiretroviral therapy, with a few more tests and experiments, it could be ready for human trials within the upcoming year or two.
